Navigation MenuRealWire Limited

Delivering Relevance, Releasing Influence



Oncolytic viruses mediating anti-tumor immunity in human cancer patients published by Oncos Therapeutics and University of Helsinki

Oncos Therapeutics have publisheda report containing initial results from their Advanced Therapy Access Program in Cancer Research. The results demonstrate anti-tumor immunity of oncolytic viruses and indicate strong efficacy of the next generation viruses against solid tumor cancers. This research will appeal medical and bioscience professionals who are interested in the latest leading developments, like those who read This leading US medical and scientific research website is a great platform for Oncos Therapeutics' research to be showcased to a relevant audience.


RealWire Influence Rating3 starReadership: 1,500,000

Oncolytic viruses mediating anti-tumor immunity in human cancer patients is a leading web-based science, research and technology news service which covers a full range of topics. These include physics, earth science, medicine, nanotechnology, electronics, space, biology, chemistry, computer sciences, engineering and mathematics. Launched in 2004,'s readership has grown steadily to include 1.5 million scientists, medical researchers, and engineers every month. publishes approximately 100 quality articles every day, offering some of the most comprehensive coverage of sci-tech developments world-wide.